{"id":496757,"date":"2024-01-24T19:00:00","date_gmt":"2024-01-25T00:00:00","guid":{"rendered":"https:\/\/platohealth.ai\/coopercompanies-announces-release-date-for-first-quarter-2024-biospace\/"},"modified":"2024-01-26T07:25:32","modified_gmt":"2024-01-26T12:25:32","slug":"coopercompanies-announces-release-date-for-first-quarter-2024-biospace","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/coopercompanies-announces-release-date-for-first-quarter-2024-biospace\/","title":{"rendered":"CooperCompanies Announces Release Date for First Quarter 2024 | BioSpace","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — CooperCompanies<\/a><\/strong> (Nasdaq: COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.<\/p>\n The dial-in number for the call is 800-715-9871 and the conference ID is 5337119. A simultaneous audio webcast and subsequent replay can be accessed at http:\/\/investor.coopercos.com<\/a>.<\/p>\n About CooperCompanies<\/strong> Contact: <\/a><\/p>\n SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":496762,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[52],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/496757"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=496757"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/496757\/revisions"}],"predecessor-version":[{"id":496761,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/496757\/revisions\/496761"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/496762"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=496757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=496757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=496757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women\u2019s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (\u201cCooper\u201d) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com<\/u><\/a>.<\/p>\n
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com<\/u><\/a><\/p>\n
<\/p>\n\n